Digital info vs standard leaflets for advanced sarcoma
Part of Brain & nervous system, Cancer clinical trials.
This trial is testing a digital tool (like videos or online info) to help people with advanced sarcoma understand their treatment better. It compares the digital tool to standard printed leaflets to see which improves understanding and wellbeing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a soft tissue or visceral sarcoma (not bone sarcoma)
- Your sarcoma cannot be removed by surgery (inoperable) and has spread or is locally advanced
- You are about to start treatment with one of these drugs: pazopanib, trabectedin, eribulin, ifosfamide, or dacarbazine
- You are covered by French social security
- You can understand and read French well
- You have access to a computer
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether having a palliative care specialist meet with patients early during an unplanned hospital stay improves their care and quality of life. Palliative care focuses on comfort and symptom management, and this trial aims to see if adding it to usual treatment helps.
This study tests whether a digital app or online tool can help you better manage symptoms and side effects from your sarcoma treatment. Researchers want to see if tracking your symptoms online improves how you feel during cancer care.
This study tests whether watching short educational videos helps patients or caregivers of someone with advanced sarcoma that has spread. The trial focuses on people who haven't had any prior treatment for their sarcoma and are comfortable filling out questionnaires in English.
This trial is testing whether a combination of two drugs—a targeted therapy (surufatinib) and an immunotherapy (envafolimab)—can help people with advanced soft tissue sarcoma that has spread or cannot be removed by surgery. Researchers will also use a person's genetic information and scans to see if they can predict who will benefit the most.
This study looks at stored tumor tissue (or takes a new biopsy) to measure specific tumor markers. Researchers want to see whether these markers match how well chemotherapy works before surgery for soft-tissue sarcoma.
This trial tests a combination of a PARP inhibitor drug, targeted radiation (SBRT), and immunotherapy for people with advanced sarcoma that has spread. It aims to see if this triple therapy can shrink tumors or slow the disease.
Hear when a new Sarcoma Metastatic trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.